Your browser doesn't support javascript.
loading
Patient-reported physical well-being predicts good long-term survival of hematopoietic stem cell transplantation.
Lu, Yin; You, Tao; Ma, Qin; Wang, Weijuan; Qi, Jiaqian; Yang, Pan; Song, Yaya; Chen, Jia; Fu, Jianhong; Ge, Yongqin; Zhu, Xiaming; Wu, Depei.
Afiliação
  • Lu Y; National Clinical Research Center for Hematologic Diseases, Suzhou, China.
  • You T; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ma Q; Hematopoietic Transplant Institute, Soochow University, Suzhou, China.
  • Wang W; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Qi J; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Yang P; National Clinical Research Center for Hematologic Diseases, Suzhou, China.
  • Song Y; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Chen J; Hematopoietic Transplant Institute, Soochow University, Suzhou, China.
  • Fu J; Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
  • Ge Y; Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.
  • Zhu X; National Clinical Research Center for Hematologic Diseases, Suzhou, China.
  • Wu D; Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Cancer Med ; 13(13): e7409, 2024 Jul.
Article em En | MEDLINE | ID: mdl-38967515
ABSTRACT

AIM:

This study aimed to explore the association between patient-reported items at different time points after hematopoietic stem cell transplantation (HSCT) and long-term survival.

METHODS:

We conducted a study with 144 allogeneic HSCT patients, following them for 5 years post-transplantation. Data from the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) questionnaire were collected before transplantation and at 1, 3, 6, 12, 18, 36, and 60 months after transplantation. Demographic characteristics and survival status were also assessed.

RESULTS:

Among the 144 cases, the 5-year overall survival (OS), progression-free survival (PFS), non-relapse mortality (NRM), and graft-versus-host disease-free (GRFS) rates were 65%, 48%, 17%, and 36% respectively. Health-related quality of life (HRQOL) showed a fluctuating pattern over 5 years. Using a latent class mixed model, patients were classified into two groups based on their physical well-being (PWB) scores during the 60-month follow-up. Class 1 had initially lower PWB scores, which gradually increased over time. In contrast, Class 2 maintained higher PWB scores with slight increases over time. Kaplan-Meier survival analysis revealed that Class 1 had better OS (70.9% vs. 52.9%, p = 0.021), PFS (60.5% vs. 41.2%, p = 0.039), and GRFS (35.1% vs. 29.3%, p = 0.035) compared to Class 2.

CONCLUSIONS:

Patients who had higher initial PWB scores after HSCT demonstrated improved long-term survival outcomes. The PWB score could serve as a valuable predictor for the prognosis of HSCT.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Células-Tronco Hematopoéticas / Medidas de Resultados Relatados pelo Paciente Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Transplante de Células-Tronco Hematopoéticas / Medidas de Resultados Relatados pelo Paciente Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article